September 22-25, 2018

CIRSE 2018

Lisbon, Portugal

The CIRSE and IDEAS Scientific Programme Committees have combined cutting-edge science with innovative learning to produce an exciting educational programme. BTG is proud to participate in this important meeting and showcase our Interventional Oncology and Vascular portfolios.

No company endeavours to do more than BTG to help doctors in their quest to see more, reach further and treat smarter. Our growing portfolio of Interventional Medicine products is designed to advance the treatment of cancer and vascular conditions.

BTG Interventional Oncology

Interventional Oncology will be front and centre, highlighting our wide range of minimally-invasive, image-guided treatment options with specific focus on DC Bead LUMI, TheraSphere and our new IceFx cryoablation system as part of the IO Ablation portfolio.

We are also excited to share that we will host multiple product theatre sessions on the BTG booth, seating 35 attendees with closed circuit audio. Click here to see a full list of sessions:

BTG Vascular

BTG's Vascular team is thrilled to showcase the new portable EKOS system. We will introduce and highlight the new line of crossing devices, providing a hands-on opportunity to track both the CenterCross and MicroCross devices through lesions.

Setting the standard in vascular therapies by making the most challenging cases easier